Use of the Cygnus GlucoWatch biographer at a diabetes camp

被引:20
|
作者
Gandrud, LM
Paguntalan, HU
Van Wyhe, MM
Kunselman, BL
Leptien, AD
Wilson, DM
Eastman, RC
Buckingham, BA
机构
[1] Stanford Univ, Sch Med, Dept Pediat Endocrinol & Diabet, Stanford, CA 94305 USA
[2] Cygnus Inc, Redwood City, CA USA
关键词
Cygnus GlucoWatch biographer; diabetes camp; hypoglycemia;
D O I
10.1542/peds.113.1.108
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background. Detection and prevention of nocturnal hypoglycemia is a major medical concern at diabetes camps. Objective. We conducted an open-label trial of the Cygnus GlucoWatch biographer to detect nocturnal hypoglycemia in a diabetes camp, a nonclinical environment with multiple activities. Methods. Forty-five campers (7-17 years old) wore a biographer. The biographer was placed on the arm at 6: 00 PM, with the low alarm set to 85 mg/dL (4.7 mmol/L). Overnight glucose monitoring occurred per usual camp protocol. Counselors were to check and record blood glucose values if the biographer alarmed. Results. Biographers were worn for 154 nights by 45 campers. After a 3-hour warm-up period, 67% of biographers were calibrated, of which 28% were worn the entire night (12 hours). Thirty-four percent of readings were skipped because of: "data errors" (65%), sweat (20%), and temperature change (16%). Reported biographer values correlated with meter glucose values measured 11 to 20 minutes later (r = 0.90). Of 20 low-glucose alarms with corresponding meter values measured within 20 minutes, there were 10 true-positive alarms, 10 false-positive alarms, and no false-negative alarms. Campers reported sleep disruption 32% of the nights, and 74% found the biographer helpful. Campers reported they would wear the biographer 4 to 5 nights each week. Conclusions. Half of the biographer low-glucose alarms that had corresponding blood meter values were true-positive alarms, and the remaining were false-positive alarms. There was close correlation between the biographer and meter glucose values. The majority of campers found the biographer helpful and would use it at home.
引用
收藏
页码:108 / 111
页数:4
相关论文
共 50 条
  • [31] Use of liraglutide in type 1 diabetes: implications for management
    Simmons, David
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (03) : 190 - 191
  • [32] Beyond Glucose Monitoring: Multianalyte Sensor Use in Diabetes
    Zhou, Kathy
    James, Steven
    Gaca, Michele
    Lecamwasam, Ashani
    Dervisevic, Muamer
    O'Neal, David
    Voelcker, Nicolas H.
    Ekinci, Elif I.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2024, 26 (12) : 885 - 896
  • [33] Linagliptin use in older individuals with type 2 diabetes
    Pratley, Richard E.
    CLINICAL INTERVENTIONS IN AGING, 2014, 9 : 1109 - 1114
  • [34] Use of Biosensors in Diabetes Monitoring: Medical and Economic Aspects
    Hadzovic, Haris
    Alic, Minela
    Dedovic, Anida
    Susic, Anesa
    Tatlic, Berina
    Zorlak, Zerina
    Zigic, Nermina
    Malenica, Maja
    Bego, Tamer
    PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON MEDICAL AND BIOLOGICAL ENGINEERING, CMBEBIH 2019, 2020, 73 : 761 - 768
  • [35] Optimizing the use of technology to support people with diabetes: research recommendations from Diabetes UK's 2019 diabetes and technology workshop
    Wylie, Thomas A. F.
    Shah, Chandrabala
    Burgess, Lucie
    Robertson, Elizabeth
    Dupont, David
    Swindell, Robin
    Hovorka, Roman
    Murphy, Helen R.
    Heller, Simon R.
    DIABETIC MEDICINE, 2021, 38 (11)
  • [36] Home Use of an Artificial Beta Cell in Type 1 Diabetes
    Thabit, H.
    Tauschmann, M.
    Allen, J. M.
    Leelarathna, L.
    Hartnell, S.
    Wilinska, M. E.
    Acerini, C. L.
    Dellweg, S.
    Benesch, C.
    Heinemann, L.
    Mader, J. K.
    Holzer, M.
    Kojzar, H.
    Exall, J.
    Yong, J.
    Pichierri, J.
    Barnard, K. D.
    Kollman, C.
    Cheng, P.
    Hindmarsh, P. C.
    Campbell, F. M.
    Arnolds, S.
    Pieber, T. R.
    Evans, M. L.
    Dunger, D. B.
    Hovorka, R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (22) : 2129 - 2140
  • [37] Use of metformin and vildagliptin for treatment of type 2 diabetes in the elderly
    Sicras-Mainar, Antoni
    Navarro-Artieda, Ruth
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 : 811 - 818
  • [38] Use of Continuous Glucose Monitoring in Patients with Type 1 Diabetes
    Ellis, Samuel L.
    Naik, Ramachandra G.
    Gemperline, Kate
    Garg, Satish K.
    CURRENT DIABETES REVIEWS, 2008, 4 (03) : 207 - 217
  • [39] Use of Intensive Glycemic Management in Older Adults with Diabetes Mellitus
    Arnold, Suzanne V.
    Lipska, Kasia J.
    Wang, Jingyan
    Seman, Leo
    Mehta, Sanjeev N.
    Kosiborod, Mikhail
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 (06) : 1190 - 1194
  • [40] Clinical Recommendations for the Use of the Ambulatory Glucose Profile in Diabetes Care
    Kroeger, Jens
    Reichel, Andreas
    Siegmund, Thorsten
    Ziegler, Ralph
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2020, 14 (03): : 586 - 594